Back to Gastroenterology
Gastroenterologyv1987Evidence-Based

Mayo Score/Disease Activity Index (DAI) for Ulcerative Colitis

Assesses severity of ulcerative colitis using four clinical and endoscopic parameters. Originally developed in 1987 to standardize assessment of ulcerative colitis activity and treatment response in clinical trials and practice. Widely used instrument for evaluating disease severity and monitoring therapeutic outcomes.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
mayo dai score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Mayo Score/Disease Activity Index (DAI) for Ulcerative Colitis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Mayo DAI Score = Stool Frequency points + Rectal Bleeding points + Mucosal Appearance points + Physician Global Assessment points. Maximum score 12 points.

Clinical Pearls & Practice Notes

  • Originally developed in 1987 by Schroeder et al. during clinical trial of 5-ASA
  • Most widely adopted disease activity index for ulcerative colitis in clinical trials (49.5% adoption rate)
  • Correlates closely with quality of life measures in patients with ulcerative colitis
  • Remission defined as total score ≤2 with no individual component >1 point
  • Mucosal healing defined as endoscopic subscore of 0 or 1
  • Clinically meaningful change defined as ≥3 point reduction in total score
  • Partial Mayo Score excludes endoscopic component (range 0-9 points)
  • Non-invasive 6-point score includes only stool frequency and rectal bleeding
  • Endoscopic component shows greatest inter-observer variation (κ = 0.38)
  • Widely used in FDA regulatory trials for ulcerative colitis treatments
  • Physician assessment should consider extraintestinal manifestations
  • Score does not predict need for surgical intervention
  • Regular reassessment recommended to monitor treatment response
  • Can be used to guide treatment escalation or de-escalation decisions

Evidence & Literature Citations

  1. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987 Dec 24;317(26):1625-9. doi: 10.1056/NEJM198712243172603.
  2. D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007 Feb;132(2):763-86. doi: 10.1053/j.gastro.2006.12.038.
  3. Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008 Dec;14(12):1660-6. doi: 10.1002/ibd.20520.
  4. Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.

Score Interpretation Ranges

Remission0 – 2 pts

Disease remission

Mild Disease3 – 5 pts

Mildly active disease

Moderate Disease6 – 10 pts

Moderately active disease

Severe Disease11 – 12 pts

Severely active disease

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.